SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-18-011350
Filing Date
2018-08-17
Accepted
2018-08-17 16:16:10
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO ANNUAL REPORT f10k2017a1_soligenixinc.htm 10-K/A 109014
2 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RULES f10k2017a1ex31-3_soligenix.htm EX-31.3 3416
3 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RULES f10k2017a1ex31-4_soligenix.htm EX-31.4 3436
  Complete submission text file 0001213900-18-011350.txt   117159
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-14778 | Film No.: 181025963
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences